Xiaolu Tao

President of Harbour Therapeutics at Harbour BioMed

Dr. Xiaolu Tao, is the Chief Development Officer. Prior to joining Harbour BioMed, Dr. Tao served as Head of Clinical Pharmacology & Bioassay at Cstone. Before moving back to China, Dr. Tao worked at BMS as Clinical Pharmacology Director in the therapeutic areas of immunology and oncology for multiple innovative products.

Org chart

Manager

Jingsong Wang

Founder, Chairman & Chief Executive Officer

Peers

Weihao Xu

President of Harbour BioMed, US & Chief Business Officer

Yiping Rong

Chief Scientific Officer

Louis Liu

Senior Vice President, Antibody Technology Platform

Timeline

President of Harbour Therapeutics
Current role
Chief Development Officer

View in org chart